Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05984680 · ClinicalTrials.gov registry record
COPD Care Pathway Among Patients With Cancer
A clinical trial of Lung Cancer and Head and Neck Cancer, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- 101
- Enrollment target
- 1
- Study location
NCT05984680: Recruiting study of Lung Cancer and Head and Neck Cancer, sponsored by Wake Forest University Health Sciences.
NCT05984680 is a study of Lung Cancer and Head and Neck Cancer that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 101 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05984680, a study of Lung Cancer and Head and Neck Cancer, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- 101 participants
- Enrollment target
- 1
- Study location
Study Summary
This study gathers information for the development of a COPD care pathway for patients with cancer that reduces the treatment burden of patients, implements critical components of COPD care, and overcomes common barriers to COPD care in the community oncology clinic.
Primary Outcome
The feasibility of designing a novel COPD care pathway for patients with cancer that is responsive to mixed methods data by specifically addressing (i) the reduction of treatment burden of patients, (ii) the implementation of important and feasible components of COPD care, and (iii) the adaptation necessary to overcome common barriers to COPD care in the community oncology clinic, with feasibility defined by the agreement of a supermajority of stakeholders at a design team workshop.
Conditions Studied
Interventions
- OTHER Observational Phase 1
- OTHER Observational Phase 2, Group I
- OTHER Observational Phase 2, Group II
- OTHER Observational Phase 3
Study Locations (1)
North Carolina
- Wake Forest Baptist Comprehensive Cancer Center - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2025-02-27 |
| Est. Completion | 2026-05 |
What NCT05984680 shows while recruiting
NCT05984680 is an observational study that tracks outcomes without assigning an intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (89% lower).
The record links to 3 conditions, with Lung Cancer appearing as the primary indexed condition, and to 4 interventions - of which Observational Phase 1 is the first listed.
NCT05984680 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05984680 about?
NCT05984680 is a clinical study titled "COPD Care Pathway Among Patients With Cancer". This study gathers information for the development of a COPD care pathway for patients with cancer that reduces the treatment burden of patients, implements critical components of COPD care, and overcomes common barriers to COPD care in the community oncology clinic.
What is the current status of trial NCT05984680?
This trial is currently recruiting. The enrollment target is 101 participants. The study started on 2025-02-27. Estimated completion is 2026-05.
What conditions does trial NCT05984680 study?
This clinical trial studies the following conditions: Lung Cancer, Head and Neck Cancer, Chronic Obstructive Pulmonary Disease.
What interventions are being tested in trial NCT05984680?
The interventions under investigation include: Observational Phase 1 (OTHER), Observational Phase 2, Group I (OTHER), Observational Phase 2, Group II (OTHER), Observational Phase 3 (OTHER).
Who is sponsoring clinical trial NCT05984680?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05984680 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05984680's enrollment target sits among peer trials
101 185th of 409 higher than 225 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04033497 · 101 participants · NA
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
- NCT05111574 · 101 participants · Phase 2
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
- NCT06266299 · 101 participants · Phase 1
A Study of KK2269 in Adult Participants With Solid Tumors
- NCT06942949 · 101 participants · NA
Evaluation of Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stones, A Pivotal Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI